Coartem Approval History 
- FDA approved: Yes (First approved April 7th, 2009)
- Brand name: Coartem
- Generic name: artemether and lumefantrine
- Company: Novartis
- Treatment for: Malaria
Coartem (artemether and lumefantrine) is an artemisinin-based combination treatment for the treatment of malaria.
FDA Approval History for Coartem
| Date | Article |
|---|---|
| Apr 8, 2009 |  Coartem receives FDA approval becoming first artemisinin-based combination treatment (ACT) for malaria in the US |
See also...
Coartem (artemether and lumefantrine) Consumer Information
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
